Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk.

× No keyword cloud information.

10 in total

1. A case report looking at ACE inhibitors as the cause of angioedema during dental treatment.

Authors: P Raval
Journal: Br Dent J Date: 2014-01 Impact factor: 1.626

2. Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors.

Authors: Seyed H Mahmoudpour; Abirami Veluchamy; Moneeza K Siddiqui; Folkert W Asselbergs; Patrick C Souverein; Catherine E de Keyser; Albert Hofman; Chim C Lang; Alexander S F Doney; Bruno H Stricker; Anthonius de Boer; Anke H Maitland-van der Zee; Colin N A Palmer
Journal: Pharmacogenet Genomics Date: 2017-03 Impact factor: 2.089

Review 3. Telmisartan: a review of its use in cardiovascular disease prevention.

Authors: James E Frampton
Journal: Drugs Date: 2011-04-16 Impact factor: 9.546

Review 4. Angioedema due to C1 inhibitor deficiency in 2010.

Authors: Marco Cicardi; Andrea Zanichelli
Journal: Intern Emerg Med Date: 2010-05-22 Impact factor: 3.397

5. Angiotensin-converting enzyme inhibitors and angioedema.

Authors: Mario Sánchez-Borges; Luis A González-Aveledo
Journal: Allergy Asthma Immunol Res Date: 2010-05-06 Impact factor: 5.764

Review 6. Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk.

Authors: Csaba Farsang
Journal: Vasc Health Risk Manag Date: 2011-09-26

Review 7. What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?

Authors: Samir G Mallat
Journal: Cardiovasc Diabetol Date: 2012-04-10 Impact factor: 9.951

8. Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway.

Authors: Abdulgafoor Muslim Tharayil; Arshad Hussain Chanda; Hakim Ahmad Shiekh; Mohamed Saad Elkhatib; Mohammed Nayeemuddin; Abdelhafiz Ali Ahmed Alshamandy
Journal: Qatar Med J Date: 2014-12-09

Review 9. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors: Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal: Pharmacol Rev Date: 2019-10 Impact factor: 25.468

10. Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme.

Authors: Urvashi Sharma; Gyles E Cozier; Edward D Sturrock; K Ravi Acharya
Journal: J Med Chem Date: 2020-05-08 Impact factor: 7.446

10 in total